About this trial
After stoma closure, pain remains an important problem affecting patient recovery. A revised paravertebral block (r-PVB) was developed as a single-shot, large-volume intercostal-space injection performed at the exposed mid-axillary ninth to eleventh intercostal level with the patient kept supine after induction of anesthesia. Rather than puncturing the classical paraspinal target near the transverse process with the patient in a prone or lateral position, the r-PVB technique is designed to exploit retrograde spread of local anesthetic from the intercostal space to the paravertebral space, thereby generating a functional paravertebral block while avoiding direct entry into the paravertebral space and the need for specific body positioning. The r-PVB technique addresses several practical limitations of conventional PVB by eliminating the need to reposition an anesthetized patient, using a more accessible and potentially clearer sonographic window, reducing interference from transverse-process shadowing, and facilitating in-plane needle visualization.
Eligibility criteria
Qualifiers
Adults aged 18 years or older.
Patients scheduled to undergo elective ileostomy, colostomy, or ileocolostomy reversal surgery.
Disqualifiers
Contraindications to nerve block, including skin infection at the puncture site, increased intracranial pressure, uncorrectable coagulopathy, bridging indication for therapeutic anticoagulation (CHADS-VASc ≥8), sepsis, or allergy to local anesthetics.
Expected operative time longer than 150 minutes, or stoma reversal not being the primary surgical procedure.
Chronic opioid use.
Heart failure, liver failure, renal failure, coagulation disorders, or a history of allergy to local anesthetics.
Trial design
Treatments tested in this trial
- Revised-Paravertebral Nerve Block